Characterization of the interaction of Aha1 with components of the Hsp90 chaperone machine and client proteins

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1823, Issue 6, 2012, Pages 1092-1101

  Sun, Liang ^a   Prince, Thomas ^a,b   Manjarrez, Jacob R ^a   Scroggins, Bradley T ^a,b   Matts, Robert L ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Activator of Hsp90 ATPase; Aha1 interacting protein; Heat shock protein 90; Hsp90 inhibitor; Non receptor tyrosine kinase v Src; Progesterone receptor

Indexed keywords

AHA1 PROTEIN; CELL CYCLE PROTEIN 37; CELL EXTRACT; CHAPERONE; DNAJA1 PROTEIN; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 90; LUCIFERASE; MOLYBDIC ACID; PROGESTERONE RECEPTOR; PROTEIN; STEROID RECEPTOR; STEROID RECEPTOR COACTIVATOR 1; STI1 PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LYSATE; COMPLEX FORMATION; CONTROLLED STUDY; DNA REPAIR; ENZYME DENATURATION; EXPERIMENTAL RABBIT; GENE OVEREXPRESSION; HELA CELL; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RNA SPLICING; WESTERN BLOTTING; YEAST;

ANIMALS; CELL EXTRACTS; HELA CELLS; HSP90 HEAT-SHOCK PROTEINS; HUMANS; LUCIFERASES; MOLECULAR CHAPERONES; MULTIPROTEIN COMPLEXES; ONCOGENE PROTEIN PP60(V-SRC); PROTEIN BINDING; PROTEIN RENATURATION; RABBITS; RECEPTORS, PROGESTERONE;

ORYCTOLAGUS CUNICULUS;

EID: 84860356248     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2012.03.014     Document Type: Article

References (67)

1. Pearl L.H., Prodromou C. Structure and mechanism of the hsp90 molecular chaperone machinery. Annu. Rev. Biochem. 2006, 75:271-294.
2. Pearl L.H., Prodromou C., Workman P. The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem. J. 2008, 410:439-453.
3. Pratt W.B., Toft D.O. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp. Biol. Med. 2003, 228:111-133. (Maywood).
4. Lotz G.P., Lin H., Harst A., Obermann W.M. Aha1 binds to the middle domain of Hsp90, contributes to client protein activation, and stimulates the ATPase activity of the molecular chaperone. J. Biol. Chem. 2003, 278:17228-17235.
5. Panaretou B., Siligardi G., Meyer P., Maloney A., Sullivan J.K., Singh S., Millson S.H., Clarke P.A., Naaby-Hansen S., Stein R., Cramer R., Mollapour M., Workman P., Piper P.W., Pearl L.H., Prodromou C. Activation of the ATPase activity of hsp90 by the stress-regulated cochaperone aha1. Mol. Cell. 2002, 10:1307-1318.
6. Harst A., Lin H., Obermann W.M. Aha1 competes with Hop, p50 and p23 for binding to the molecular chaperone Hsp90 and contributes to kinase and hormone receptor activation. Biochem. J. 2004.
7. Meyer P., Prodromou C., Liao C., Hu B., Mark Roe S., Vaughan C.K., Vlasic I., Panaretou B., Piper P.W., Pearl L.H. Structural basis for recruitment of the ATPase activator Aha1 to the Hsp90 chaperone machinery. EMBO J. 2004, 23:511-519.
8. Siligardi G., Hu B., Panaretou B., Piper P.W., Pearl L.H., Prodromou C. Co-chaperone regulation of conformational switching in the Hsp90 ATPase cycle. J. Biol. Chem. 2004, 279:51989-51998.
9. Koulov A.V., Lapointe P., Lu B., Razvi A., Coppinger J., Dong M.Q., Matteson J., Laister R., Arrowsmith C., Yates J.R., Balch W.E. Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis. Mol. Biol. Cell. 2010, 21:871-884.
10. Retzlaff M., Hagn F., Mitschke L., Hessling M., Gugel F., Kessler H., Richter K., Buchner J. Asymmetric activation of the hsp90 dimer by its cochaperone aha1. Mol. Cell. 2010, 37:344-354.
11. Nathan D.F., Vos M.H., Lindquist S. Identification of SSF1, CNS1, and HCH1 as multicopy suppressors of a Saccharomyces cerevisiae Hsp90 loss-of-function mutation. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:1409-1414.
12. Harst A., Lin H., Obermann W.M. Aha1 competes with Hop, p50 and p23 for binding to the molecular chaperone Hsp90 and contributes to kinase and hormone receptor activation. Biochem. J. 2005, 387:789-796.
13. Sevier C.S., Machamer C.E. p38: a novel protein that associates with the vesicular stomatitis virus glycoprotein. Biochem. Biophys. Res. Commun. 2001, 287:574-582.
14. Sun F., Mi Z., Condliffe S.B., Bertrand C.A., Gong X., Lu X., Zhang R., Latoche J.D., Pilewski J.M., Robbins P.D., Frizzell R.A. Chaperone displacement from mutant cystic fibrosis transmembrane conductance regulator restores its function in human airway epithelia. FASEB J. 2008, 22:3255-3263.
15. Wang X., Venable J., LaPointe P., Hutt D.M., Koulov A.V., Coppinger J., Gurkan C., Kellner W., Matteson J., Plutner H., Riordan J.R., Kelly J.W., Yates J.R., Balch W.E. Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. Cell 2006, 127:803-815.
16. Fuller W., Cuthbert A.W. Post-translational disruption of the delta F508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes delta F508 CFTR in the rabbit reticulocyte lysate. J. Biol. Chem. 2000, 275:37462-37468.
17. Loo M.A., Jensen T.J., Cui L., Hou Y., Chang X.B., Riordan J.R. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J. 1998, 17:6879-6887.
18. Meimaridou E., Gooljar S.B., Ramnarace N., Anthonypillai L., Clark A.J., Chapple J.P. The cytosolic chaperone Hsc70 promotes traffic to the cell surface of intracellular retained melanocortin-4 receptor mutants. Mol. Endocrinol. 2011.
19. Bhangoo M.K., Tzankov S., Fan A.C., Dejgaard K., Thomas D.Y., Young J.C. Multiple 40-kDa heat-shock protein chaperones function in Tom70-dependent mitochondrial import. Mol. Biol. Cell 2007, 18:3414-3428.
20. Zhong X.Y., Ding J.H., Adams J.A., Ghosh G., Fu X.D. Regulation of SR protein phosphorylation and alternative splicing by modulating kinetic interactions of SRPK1 with molecular chaperones. Genes Dev. 2009, 23:482-495.
21. Holmes J.L., Sharp S.Y., Hobbs S., Workman P. Silencing of HSP90 cochaperone AHA1 expression decreases client protein activation and increases cellular sensitivity to the HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin. Cancer Res. 2008, 68:1188-1197.
22. Swick L., Kapatos G. A yeast 2-hybrid analysis of human GTP cyclohydrolase I protein interactions. J. Neurochem. 2006, 97:1447-1455.
23. Ran F., Gadura N., Michels C.A. Hsp90 cochaperone Aha1 is a negative regulator of the Saccharomyces MAL activator and acts early in the chaperone activation pathway. J. Biol. Chem. 2010, 285:13850-13862.
24. Thulasiraman V., Matts R.L. Effect of geldanamycin on the kinetics of chaperone-mediated renaturation of firefly luciferase in rabbit reticulocyte lysate. Biochemistry 1996, 35:13443-13450.
25. cdc37 function during the biogenesis of the active conformation of the heme-regulated eIF2α kinase. J. Biol. Chem. 2001, 276:206-214.
26. Yun B.-G., Huang W., Leach N., Hartson S.D., Matts R.L. Novobiocin induces a distinct conformation of Hsp90 and alters Hsp90-cochaperone-client interactions. Biochemistry 2004, 43:8217-8229.
27. Shao J., Hartson S.D., Matts R.L. Evidence that protein phosphatase 5 functions to negatively modulate the maturation of the Hsp90-dependent heme-regulated eIF2alpha kinase. Biochemistry 2002, 41:6770-6779.
28. Smith D.F., Sullivan W.P., Marion T.N., Zaitsu K., Madden B., McCormick D.J., Toft D.O. Identification of a 60-kilodalton stress-related protein, p60, which interacts with hsp90 and hsp70. Mol. Cell. Biol. 1993, 13:869-876.
29. cdc37 as a non-exclusive Hsp90 cohort which participates in Hsp90-mediated folding of immature kinase molecules. Biochemistry 2000, 39:7631-7644.
30. Johnson J.L., Toft D.O. A novel chaperone complex for steroid hormone receptors involving heat shock proteins, immunophilins and p23. J. Biol. Chem. 1994, 269:24989-24993.
31. Tai P.K., Maeda Y., Nakao K., Wakim N.G., Duhring J.L., Faber L.E. A 59-kilodalton protein associated with progestin, estrogen, androgen, and glucocorticoid receptors. Biochemistry 1986, 25:5269-5275.
32. Prapapanich V., Chen S., Nair S.C., Rimerman R.A., Smith D.F. Molecular cloning of human p48, a transient component of progesterone receptor complexes and an Hsp70-binding protein. Mol. Endocrinol. 1996, 10:420-431.
33. Keller A., Nesvizhskii A.I., Kolker E., Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal. Chem. 2002, 74:5383-5392.
34. Matts R.L., Manjarrez J.R. Assays for identification of Hsp90 inhibitors and biochemical methods for discriminating their mechanism of action. Curr. Top Med. Chem. 2009, 9:1462-1478.
35. McLaughlin S.H., Smith H.W., Jackson S.E. Stimulation of the weak ATPase activity of human hsp90 by a client protein. J. Mol. Biol. 2002, 315:787-798.
36. Hartson S.D., Thulasiraman V., Huang W., Whitesell L., Matts R.L. Molybdate inhibits hsp90, induces structural changes in its C-terminal domain, and alters its interactions with substrates. Biochemistry 1999, 38:3837-3849.
37. Scroggins B.T., Prince T., Shao J., Uma S., Huang W., Guo Y., Yun B.G., Hedman K., Matts R.L., Hartson S.D. High affinity binding of Hsp90 is triggered by multiple discrete segments of its kinase clients. Biochemistry 2003, 42:12550-12561.
38. Prince T., Matts R.L. Definition of protein kinase sequence motifs that trigger high affinity binding of Hsp90 and Cdc37. J. Biol. Chem. 2004, 279:39975-39981.
39. Yun B.G., Matts R.L. Hsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiation. Cell. Signal. 2005, 17:1477-1485.
40. Li J., Richter K., Buchner J. Mixed Hsp90-cochaperone complexes are important for the progression of the reaction cycle. Nat. Struct. Mol. Biol. 2011, 18:61-66.
41. Ali M.M., Roe S.M., Vaughan C.K., Meyer P., Panaretou B., Piper P.W., Prodromou C., Pearl L.H. Crystal structure of an Hsp90-nucleotide-p23/Sba1 closed chaperone complex. Nature 2006, 440:1013-1017.
42. McLaughlin S.H., Sobott F., Yao Z.P., Zhang W., Nielsen P.R., Grossmann J.G., Laue E.D., Robinson C.V., Jackson S.E. The co-chaperone p23 arrests the Hsp90 ATPase cycle to trap client proteins. J. Mol. Biol. 2006, 356:746-758.
43. Gaiser A.M., Kretzschmar A., Richter K. Cdc37-Hsp90 complexes are responsive to nucleotide-induced conformational changes and binding of further cofactors. J. Biol. Chem. 2010, 285:40921-40932.
44. Richter K., Moser S., Hagn F., Friedrich R., Hainzl O., Heller M., Schlee S., Kessler H., Reinstein J., Buchner J. Intrinsic inhibition of the Hsp90 ATPase activity. J. Biol. Chem. 2006, 281:11301-11311.
45. Karagoz G.E., Duarte A.M., Ippel H., Uetrecht C., Sinnige T., van Rosmalen M., Hausmann J., Heck A.J., Boelens R., Rudiger S.G. N-terminal domain of human Hsp90 triggers binding to the cochaperone p23. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:580-585.
46. Okiyoneda T., Barriere H., Bagdany M., Rabeh W.M., Du K., Hohfeld J., Young J.C., Lukacs G.L. Peripheral protein quality control removes unfolded CFTR from the plasma membrane. Science 2010, 329:805-810.
47. Tuteja R., Tuteja N. Ku autoantigen: a multifunctional DNA-binding protein. Crit. Rev. Biochem. Mol. Biol. 2000, 35:1-33.
48. Gullo C., Au M., Feng G., Teoh G. The biology of Ku and its potential oncogenic role in cancer. Biochim. Biophys. Acta 2006, 1765:223-234.
49. Falsone S.F., Gesslbauer B., Tirk F., Piccinini A.M., Kungl A.J. A proteomic snapshot of the human heat shock protein 90 interactome. FEBS Lett. 2005, 579:6350-6354.
50. Barker C.R., McNamara A.V., Rackstraw S.A., Nelson D.E., White M.R., Watson A.J., Jenkins J.R. Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage. Nucleic Acids Res. 2006, 34:1148-1157.
51. Barker C.R., Hamlett J., Pennington S.R., Burrows F., Lundgren K., Lough R., Watson A.J., Jenkins J.R. The topoisomerase II-Hsp90 complex: a new chemotherapeutic target?. Int. J. Cancer 2006, 118:2685-2693.
52. Yano K., Morotomi-Yano K., Adachi N., Akiyama H. Molecular mechanism of protein assembly on DNA double-strand breaks in the non-homologous end-joining pathway. J. Radiat. Res. 2009, 50:97-108. (Tokyo).
53. Petri S., Grimmler M., Over S., Fischer U., Gruss O.J. Dephosphorylation of survival motor neurons (SMN) by PPM1G/PP2Cgamma governs Cajal body localization and stability of the SMN complex. J. Cell Biol. 2007, 179:451-465.
54. White C.D., Brown M.D., Sacks D.B. IQGAPs in cancer: a family of scaffold proteins underlying tumorigenesis. FEBS Lett. 2009, 583:1817-1824.
55. Brown M.D., Sacks D.B. IQGAP1 in cellular signaling: bridging the GAP. Trends Cell Biol. 2006, 16:242-249.
56. Ghosh S., Tewari R., Dixit D., Sen E. TNFalpha induced oxidative stress dependent Akt signaling affects actin cytoskeletal organization in glioma cells. Neurochem. Int. 2010, 56:194-201.
57. McCahill A., Warwicker J., Bolger G.B., Houslay M.D., Yarwood S.J. The RACK1 scaffold protein: a dynamic cog in cell response mechanisms. Mol. Pharmacol. 2002, 62:1261-1273.
58. Liu Y.V., Semenza G.L. RACK1 vs. HSP90: competition for HIF-1 alpha degradation vs. stabilization. Cell Cycle 2007, 6:656-659.
59. Liu Y.V., Baek J.H., Zhang H., Diez R., Cole R.N., Semenza G.L. RACK1 competes with HSP90 for binding to HIF-1alpha and is required for O(2)-independent and HSP90 inhibitor-induced degradation of HIF-1alpha. Mol. Cell 2007, 25:207-217.
60. Gomes-Alves P., Neves S., Coelho A.V., Penque D. Low temperature restoring effect on F508del-CFTR misprocessing: a proteomic approach. J. Proteomics 2009, 73:218-230.
61. Auerbach M., Liedtke C.M. Role of the scaffold protein RACK1 in apical expression of CFTR. Am. J. Physiol. Cell Physiol. 2007, 293:C294-C304.
62. Liedtke C.M., Wang X. The N-terminus of the WD5 repeat of human RACK1 binds to airway epithelial NHERF1. Biochemistry 2006, 45:10270-10277.
63. Liedtke C.M., Yun C.H., Kyle N., Wang D. Protein kinase C epsilon-dependent regulation of cystic fibrosis transmembrane regulator involves binding to a receptor for activated C kinase (RACK1) and RACK1 binding to Na+/H+ exchange regulatory factor. J. Biol. Chem. 2002, 277:22925-22933.
64. Schmidt A., Durgan J., Magalhaes A., Hall A. Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis. EMBO J. 2007, 26:1624-1636.
65. Harrison B.C., Huynh K., Lundgaard G.L., Helmke S.M., Perryman M.B., McKinsey T.A. Protein kinase C-related kinase targets nuclear localization signals in a subset of class IIa histone deacetylases. FEBS Lett. 2010, 584:1103-1110.
66. Dettori R., Sonzogni S., Meyer L., Lopez-Garcia L.A., Morrice N.A., Zeuzem S., Engel M., Piiper A., Neimanis S., Frodin M., Biondi R.M. Regulation of the interaction between protein kinase C-related protein kinase 2. J. Biol. Chem. 2009, 284:30318-30327.
67. Shkreta L., Michelle L., Toutant J., Tremblay M.L., Chabot B. The DNA damage response pathway regulates the alternative splicing of the apoptotic mediator Bcl-x. J. Biol. Chem. 2011, 286:331-340.